BioArctic AB

B9A

Company Profile

  • Business description

    BioArctic AB is a research-based biopharmaceutical company focusing on disease-modifying treatments and diagnostics for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, and ALS. Geographically, it derives a majority of its revenue from North America.

  • Contact

    Warfvinges vag 35
    StockholmSE-112 51
    SWE

    T: +46 86956930

    https://www.bioarctic.se

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    150

Stocks News & Analysis

stocks

Reassuring organic growth for undervalued ASX share

Efficiency gains are starting to make their mark.
stocks

Big IPOs are enticing but are they good investments?

Historically, buzzy debuts have been painful for buyers.
stocks

This defensive ASX listed REIT offers a 5% yield

Solid outlook underpinned by rent uplifts and development pipeline.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,692.80143.80-1.63%
CAC 407,982.1098.64-1.22%
DAX 4024,976.17487.64-1.92%
Dow JONES (US)49,258.00160.940.33%
FTSE 10010,394.0758.61-0.56%
HKSE22,410.80430.82-1.89%
NASDAQ23,578.02301.18-1.26%
Nikkei 22556,436.653,007.56-5.06%
NZX 50 Index14,107.41139.84-0.98%
S&P 5007,145.2930.54-0.43%
S&P/ASX 2008,592.60137.80-1.58%
SSE Composite Index3,533.7943.82-1.22%

Market Movers